Costa Rica vs Morocco: Adults (ages 15+) and children (ages 0-14) newly infected with HIV
Costa Rica
1,100
in 2024
Morocco
990
in 2024
Costa Rica rank
75th
Morocco rank
78th
Adults (ages 15+) and children (ages 0-14) newly infected with HIV over time
- Costa Rica
- Morocco
How they compare
Costa Rica currently reports 1,100 against 990 in Morocco, a difference of 110.
That makes Costa Rica's figure about 1.1 times Morocco's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Morocco ahead.
Costa Rica ranks 75th and Morocco ranks 78th of 146 countries.
Across the 4 decades both report, Costa Rica averaged higher in 1 and Morocco in 3.
Head to head by decade
| Decade | Costa Rica | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 500 | 1,120 | 620 | Morocco |
| 2000s | 720 | 1,680 | 960 | Morocco |
| 2010s | 1,043 | 1,290 | 247 | Morocco |
| 2020s | 1,100 | 1,078 | 22 | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher adults (ages 15+) and children (ages 0-14) newly infected with hiv, Costa Rica or Morocco?
- Costa Rica, at 1,100 against 990 in Morocco as of 2024.
- What is the difference in adults (ages 15+) and children (ages 0-14) newly infected with hiv between Costa Rica and Morocco?
- 110, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Morocco?
- 35 years are reported by both, from 1990 to 2024.
- How do Costa Rica and Morocco rank globally for adults (ages 15+) and children (ages 0-14) newly infected with hiv?
- Costa Rica ranks 75th and Morocco ranks 78th of 146 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Adults (ages 15+) and children (ages 0-14) newly infected with HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of adults (ages 15+) and children (ages 0-14) newly infected with HIV.